Skip to main content
. 2009 Jul 13;119(8):2257–2270. doi: 10.1172/JCI35738

Figure 3. Systemic administration of VEGF and LPS results in organ-specific increases in lacZ and DSCR-1s mRNA expression.

Figure 3

(A) Real-time PCR quantitation of lacZ expression levels in various organs from control mice, VEGF-treated mice, or LPS-treated mice. Data are expressed as mean ± standard deviation; n = 5 in each treatment. *P < 0.04, **P < 0.01 compared with mock treatment in each organ. (B) Real-time PCR quantitation of DSCR-1L and DSCR-1s mRNA expression levels in various organs from LPS-treated mice. The results are the mean and standard deviation of expression levels relative to cyclophilin A, derived from at least 4 independent mice. †P < 0.001 compared with DSCR-1s expression levels without LPS treatment.